“Commenting on the allegations against Russia is becoming more and more circus-like,” Peskov told reporters on Friday. “Russia is not giving false information about anyone, Russia proudly talks about its successes and Russia shares its successes for the first time ever registered [coronavirus] Vaccine in the world. ”
Raeb said in an interview with Sky News, “We know that Russia has got a track record in the region. Previously we commented and called them out on it.”
“But someone basically tries to sabotage the efforts of those trying to develop a vaccine that I think are profoundly condemnable. This is unacceptable and inappropriate under any circumstances.”
The Times said a “whistleblower” campaign was involved in “passing images on paper out of concern about the potential harm to public health efforts.” The newspaper has not clarified whether the campaign was directly authorized by the Kremlin, but added that “there is evidence that some Russian officials were involved in its organization and dissemination”.
Estradenesca CEO Pascal Sorot said, “False exposure to public health is a particular threat. This is especially true during the current pandemic that is claiming the lives of thousands of people, which can harm our lives and the economy.” Works. Statement.
“I urge everyone to continue to use reliable sources of information, to trust regulatory agencies and to remember vaccines and drugs for humanity.”
Discrimination is “reckless and contemptuous behavior that can cause real harm to people’s health”, said a source in Whitehall, the area in central London where major UK ministries are based. “Such lies fundamentally trouble us all around the world and we need to identify and combat such activity to support the provision of factual information about Kovid-19 and all people about vaccines.” Need to be cautious. ”
When asked to comment on the article, a Kremlin spokesman in turn accused Britain of spreading disinformation about the Russian vaccine, suggesting that it was a testament to unfair competition in the vaccine race.
“Russia already has documents of intent to sell or jointly make this vaccine in many countries, and certainly Russia in these countries does not shy away from giving information. [the public] Regarding the benefits of our vaccine, “Peskov said.” [producers] Those who can be called contests engage in dissolution, with disruptive agents sitting in other places, in Britain. ”
According to the Times, the aim of the campaign is “countries like India and Brazil where Russia was attempting to market its own vaccine” with Western countries developing their own vaccines. To date, the Russian Sovereign Wealth Fund (or RDIF), which sponsors the vaccine, said it reached deals to supply Sputnik V to India and Brazil, among others.
RDIF said it condemned the social media attacks against the AstraZeneca vaccine.
“We condemn social media posts intended by the Times to discredit the AstraZeneca vaccine. We believe that Gamalaya’s attempt to vaccinate against the Sputnik V vaccine is wrong,” RDIF CEO, Kiran Dimitrik, told CNN told. Statement Friday. “All vaccines must, of course, be subject to the most rigorous scientific investigation.”
However, the “monkey vaccine” narrative has previously been voiced by Russian authorities and state media.
On 9 September, following news of a halt in global trials of AstraZeneca due to an unexplained disease, Dmitry Peskov said the British vaccine is less safe because it is a “monkey vaccine” while the Russian growth is a “human vaccine” and is believed to be Russian. Being “much more reliable” by scientists.
Crude images depicting monkeys with “monkey vaccine is fine” and similar memories have appeared on Russian state media two days after AstraZeneca announced a halt. On September 10, the Russian state-news agency RIA Novosti published an editorial piece, titled “Why the West is losing the vaccine race: Russia has been exposed,” with four captions on the monkey vaccine with the English caption.
Testing has resumed in the UK since AstraZeneca. In the US, the FDA is considering whether to allow AstraZeneca to resume its testing after a participant is ill. The issue of whether the disease was a temporary one, or if it may be related to the vaccine.
The head of the Russian Direct Investment Fund sponsoring the development of Sputnik V said the company was “pleased” to see the AstraZeneca trial going ahead in September, but called the approach “unacceptable” due to “excessive reliance” on the new unverified goes. Technologies, “including the use of a monkey adenovirus vector or mRNA technology.
In July, however, RDIF announced that one of its portfolio companies, the pharmaceutical manufacturer R-Farm, reached an agreement with AstraZeneca to produce the Oxford vaccine in Russia. The announcement comes after warnings that artists associated with Russia are attempting to hack UK, US and Canada-based research centers to gather intelligence on vaccine production. Russia denied any involvement.
RDIF chief Kyril Dimitrig told Reuters at the time that Moscow did not need to steal any secrets because Russia already had a deal with AstraZeneca for the creation of a potential British vaccine.
In a statement in July, the R-Farm states that cell lines and adenovirus vectors have been transferred to Russia; It is planned to produce antigen and produce finished dose here. “At the same time, Russia will be one of the hubs for the production and supply of vaccines in international markets.”
Asked on Friday if AstraZeneca’s stand in trial and technology was at risk of a deal with the Russian manufacturer, Dimitrog said: “One of our portfolio companies is manufacturing the AstraZeneca vaccine. We believe that both Human senovial vector approaches that are using Sputnik V, and chimpanzee adenoviral vector approaches used by AstraZeneca are both very promising approaches on a solid basis. ”
Gamalaya is using adenoviruses in his Kovid-19 vaccines; This is the same approach used in the vaccine developed by Oxford University and AstraZeneca. The adenovirus distributes genetic material for the spike protein that sits on top of the virus that causes Kovid-19, and that genetic material is designed to induce an immune response to the virus.
Adenoviruses can cause a wide variety of symptoms, including the common cold. Researchers manipulate the virus, so it will not cause disease.
The Gamaleya vaccine is given in two doses, and each dose uses a different adenovirus vector.
Russia registered its first coronavirus vaccine Sputnik V in August after conducting trials on 76 volunteers and extensive first-stage trials. The announcement came to much fanfare from the Russian state media, but widespread skepticism was expressed from the international community about its security and the notion could be dispelled with political goals. According to Russian officials, Sputnik V is now involved in its Phase 3 trial, which has so far involved 13,000 people and intends to enroll up to 40,000.
AstraZeneca launched a large-scale Phase 3 human clinical trial in August, seeking to enroll up to 30,000. Such trials are the final step before approval from the vaccine manufacturer regulators.
Another vaccine, EpiVacCorona, developed by Vector, a former biochemical weapons lab, was registered in Russia this week before going through phase 3 trials. Phase I trials began last week, the third possible Russian vaccine from the Chumakov Institute.